🇺🇸 FDA
Pipeline program

Azilect

H13-02074

Unknown small_molecule active

Quick answer

Azilect for Parkinson's Disease is a Unknown program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Parkinson's Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials